News

GlycoMimetics, a clinical stage pharmaceutical company, has completed two Phase I safety studies of its lead drug candidate GMI-1070 for vaso-occlusive crisis of sickle cell disease. The Phase

Mylan, a US-based generic pharmaceutical company, has announced its plans to purchase the remaining interest in India-based pharmaceutical company Matrix Laboratories from minority shareholders pursuant to a voluntary

Mylan, a generic pharmaceutical company, has announced that it and/or a subsidiary has been sued in connection with four separate first-to-file abbreviated new drug applications filed with the

According to the company, with its intelligent traffic light system, Biotronik Home Monitoring provides efficient and convenient remote monitoring of patients with implantable cardiac devices. Biotronik Home Monitoring

Toctino is a new once-daily oral treatment for adults with severe chronic hand eczema unresponsive to potent topical corticosteroids. The marketing authorization application (MAA) for Toctino was submitted

Kinetic Concepts (KCI) said that the initiatives will enhance its potential to increase shareholder value and improve operational efficiency and effectiveness by streamlining its organizational structure and workforce

As consideration for the amended and restated distribution and licensing agreement, Angiotech will receive $25 million. Angiotech and Baxter initially entered into a distribution and licensing agreement in

Bill Gates joined Chinese Minister of Health Chen Zhu to announce an innovative partnership to help fight a serious tuberculosis epidemic in China. The goal of the partnership

The grants by the Connecticut Stem Cell Advisory Committee were made under a 2005 state law which designated $100 million over 10 years to promote stem cell research